Vestal Point Capital, LP
Filing Date
Global Rank
#1,138
/ 7,976
▲ 53
Top Industry
Biotechnology
77.6%
3Y Alpha vs SPY
+4.9%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
8 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+67.7%
SPY
+52.9%
Annualised alpha
+4.9%
Max drawdown
−31.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
76 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
5.7%
−4.2 pts
Top 5
22.9%
−7.6 pts
Top 10
40.2%
−6.5 pts
HHI
258
Diversified−92
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.8% | $2,105,692,121 |
| Unclassified | 0.2% | $4,103,250 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | +2,500,000 | 5,500,000 | $17,985,000 | |
| DYN | Dyne Therapeutics, Inc. | +2,047,500 | 2,775,000 | $35,103,750 | |
| NRIX | Nurix Therapeutics, Inc. | +1,475,000 | 3,475,000 | $32,109,000 | |
| SLDB | Solid Biosciences Inc. | +1,470,000 | 2,975,000 | $18,355,750 | |
| ELVN | Enliven Therapeutics, Inc. | +910,000 | 1,160,000 | $23,745,200 | |
| GMED | Globus Medical Inc | +750,000 | 1,250,000 | $71,587,500 | |
| ZYME | Zymeworks Inc. | +615,000 | 1,765,000 | $30,146,200 | |
| IONS | Ionis Pharmaceuticals Inc | +575,000 | 1,075,000 | $70,326,500 | |
| ALC | Alcon Inc | +575,000 | 1,100,000 | $81,961,000 | |
| ASND | Ascendis Pharma A/S | +400,000 | 600,000 | $119,286,000 | |
| IRON | Disc Medicine, Inc. | +360,000 | 500,000 | $33,040,000 | |
| BMRN | Biomarin Pharmaceutical Inc | +330,000 | 830,000 | $44,952,800 | |
| BDX | Becton Dickinson & Co | +300,000 | 325,000 | $47,822,515 | |
| LNTH | Lantheus Holdings, Inc. | +120,000 | 170,000 | $8,719,300 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +105,000 | 200,000 | $3,770,000 | |
| BCAX | Bicara Therapeutics Inc. | +100,000 | 5,100,000 | $80,529,000 | |
| IMTX | Immatics N.V. | +100,000 | 6,350,000 | $54,102,000 | |
| DHR | Danaher Corp /De/ | +100,000 | 150,000 | $29,739,000 | |
| ABT | Abbott Laboratories | +75,000 | 250,000 | $33,485,000 | |
| BBNX | Beta Bionics, Inc. | +50,000 | 600,000 | $11,922,000 | |
| NUVL | Nuvalent, Inc. | +25,000 | 1,100,000 | $95,128,000 | |
| LXEO | Lexeo Therapeutics, Inc. | +21,839 | 3,250,000 | $21,580,000 | |
| ALEC | Alector, Inc. | +3,008 | 980,000 | $2,900,800 | |
| TRAW | Traws Pharma, Inc. | +200 | 150,000 | $277,500 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SVRA | Savara Inc | −7,000,000 | 4,015,000 | $14,333,550 | |
| GERN | Geron Corp | −6,550,000 | 17,225,000 | $23,598,250 | |
| KALV | KalVista Pharmaceuticals, Inc. | −3,925,000 | 750,000 | $9,135,000 | |
| QURE | uniQure N.V. | −3,475,000 | 225,000 | $13,133,250 | |
| VERA | Vera Therapeutics, Inc. | −2,340,000 | 760,000 | $22,085,600 | |
| CYTK | Cytokinetics Inc | −2,250,000 | 725,000 | $39,846,000 | |
| FOLD | AMICUS THERAPEUTICS, INC. | −2,150,000 | 9,750,000 | $76,830,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −2,020,000 | 1,180,000 | $46,433,000 | |
| ACLX | Arcellx, Inc. | −1,500,000 | 1,250,000 | $102,625,000 | |
| XENE | Xenon Pharmaceuticals Inc. | −900,000 | 1,100,000 | $44,165,000 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | −750,000 | 750,000 | $31,237,500 | |
| JAZZ | Jazz Pharmaceuticals plc | −700,000 | 500,000 | $65,900,000 | |
| EXAS | EXACT SCIENCES CORP | −625,000 | 75,000 | $4,103,250 | |
| RVMD | Revolution Medicines, Inc. | −570,000 | 630,000 | $29,421,000 | |
| CLDX | Celldex Therapeutics, Inc. | −545,000 | 1,205,000 | $31,173,350 | |
| DAWN | Day One Biopharmaceuticals, Inc. | −325,000 | 2,675,000 | $18,858,750 | |
| NYXH | Nyxoah SA | −294,589 | 1,107,413 | $5,094,099 | |
| TYRA | Tyra Biosciences, Inc. | −230,000 | 2,425,000 | $33,925,750 | |
| BRKR | Bruker Corp | −60,000 | 440,000 | $14,295,600 | |
| BDTX | Black Diamond Therapeutics, Inc. | −50,000 | 5,550,000 | $21,034,500 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
24 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ABVX | Abivax S.A. | 1,000,000 | $84,900,000 | |
| RGEN | Repligen Corp | 400,000 | $53,468,000 | |
| DXCM | Dexcom Inc | 650,000 | $43,738,500 | |
| BIIB | Biogen Inc. | 275,000 | $38,522,000 | |
| RAPP | Rapport Therapeutics, Inc. | 950,000 | $28,215,000 | |
| BLTE | Belite Bio, Inc | 312,500 | $23,125,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 750,000 | $22,560,000 | |
| AXSM | Axsome Therapeutics, Inc. | 150,000 | $18,217,500 | |
| APGE | Apogee Therapeutics, Inc. | 425,000 | $16,885,250 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 25,000 | $14,056,750 | |
| BHVN | Biohaven Ltd. | 701,700 | $10,532,517 | |
| INSP | Inspire Medical Systems, Inc. | 135,000 | $10,017,000 | |
| CGON | CG Oncology, Inc. | 175,000 | $7,049,000 | |
| TVRD | Tvardi Therapeutics, Inc. | 167,000 | $6,507,990 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 800,000 | $5,928,000 | |
| GSK | GSK plc | 125,000 | $5,395,000 | |
| NVCR | NovoCure Ltd | 400,000 | $5,168,000 | |
| AGIO | Agios Pharmaceuticals, Inc. | 127,000 | $5,097,780 | |
| MYGN | Myriad Genetics Inc | 600,000 | $4,338,000 | |
| ESTA | Establishment Labs Holdings Inc. | 100,000 | $4,099,000 | |
| KOD | Kodiak Sciences Inc. | 250,000 | $4,092,500 | |
| RCUS | Arcus Biosciences, Inc. | 250,000 | $3,400,000 | |
| PASG | Passage BIO, Inc. | 305,000 | $2,449,150 | |
| LUNG | Pulmonx Corp | 830,000 | $1,344,600 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GEHC | GE HealthCare Technologies Inc. | 700,000 | $51,849,000 | |
| MLTX | MoonLake Immunotherapeutics | 550,000 | $25,960,000 | |
| COO | Cooper Companies, Inc. | 350,000 | $24,906,000 | |
| GPCR | Structure Therapeutics Inc. | 1,200,000 | $24,888,000 | |
| EW | Edwards Lifesciences Corp | 300,000 | $23,463,000 | |
| COGT | Cogent Biosciences, Inc. | 3,080,000 | $22,114,400 | |
| MDT | Medtronic plc | 195,000 | $16,998,150 | |
| PRGO | PERRIGO Co plc | 625,000 | $16,700,000 | |
| TMO | Thermo Fisher Scientific Inc. | 25,000 | $10,136,500 | |
| TVTX | Travere Therapeutics, Inc. | 355,000 | $5,254,000 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 50,000 | $4,560,500 | |
| NBIX | Neurocrine Biosciences Inc | 30,000 | $3,770,700 | |
| VRDN | Viridian Therapeutics, Inc.DE | 100,000 | $1,398,000 | |
| ATRA | Atara Biotherapeutics, Inc. | 94,085 | $726,336 | |
| No positions match the current search. | ||||
76 positions ·
$2,109,795,371 total
· as of Sep 30, 2025
Showing 1–50
of 76 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 600,000 | $119,286,000 | 5.65% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Reduced | 1,250,000 | $102,625,000 | 4.86% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 1,100,000 | $95,128,000 | 4.51% | |
| ABVX |
Abivax S.A.
Healthcare
|
NEW | 1,000,000 | $84,900,000 | 4.02% | |
| ALC |
Alcon Inc
Healthcare
|
Added | 1,100,000 | $81,961,000 | 3.88% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 5,100,000 | $80,529,000 | 3.82% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Reduced | 9,750,000 | $76,830,000 | 3.64% | |
| GMED |
Globus Medical Inc
Healthcare
|
Added | 1,250,000 | $71,587,500 | 3.39% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 1,075,000 | $70,326,500 | 3.33% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Reduced | 500,000 | $65,900,000 | 3.12% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 1,500,000 | $55,860,000 | 2.65% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 6,350,000 | $54,102,000 | 2.56% | |
| RGEN |
Repligen Corp
Healthcare
|
NEW | 400,000 | $53,468,000 | 2.53% | |
| BDX |
Becton Dickinson & Co
Healthcare
|
Added | 325,000 | $47,822,515 | 2.27% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 1,180,000 | $46,433,000 | 2.20% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 830,000 | $44,952,800 | 2.13% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 1,100,000 | $44,165,000 | 2.09% | |
| DXCM |
Dexcom Inc
Healthcare
|
NEW | 650,000 | $43,738,500 | 2.07% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 725,000 | $39,846,000 | 1.89% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 275,000 | $38,522,000 | 1.83% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 2,775,000 | $35,103,750 | 1.66% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Reduced | 2,425,000 | $33,925,750 | 1.61% | |
| ABT |
Abbott Laboratories
Healthcare
|
Added | 250,000 | $33,485,000 | 1.59% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 500,000 | $33,040,000 | 1.57% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 3,475,000 | $32,109,000 | 1.52% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 750,000 | $31,237,500 | 1.48% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,205,000 | $31,173,350 | 1.48% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Added | 1,765,000 | $30,146,200 | 1.43% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 150,000 | $29,739,000 | 1.41% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 630,000 | $29,421,000 | 1.39% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
NEW | 950,000 | $28,215,000 | 1.34% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 1,160,000 | $23,745,200 | 1.13% | |
| GERN |
Geron Corp
Healthcare
|
Reduced | 17,225,000 | $23,598,250 | 1.12% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
NEW | 312,500 | $23,125,000 | 1.10% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
NEW | 750,000 | $22,560,000 | 1.07% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 760,000 | $22,085,600 | 1.05% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 3,250,000 | $21,580,000 | 1.02% | |
| BDTX |
Black Diamond Therapeutics, Inc.
Healthcare
|
Reduced | 5,550,000 | $21,034,500 | 1.00% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
Reduced | 2,675,000 | $18,858,750 | 0.89% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 2,975,000 | $18,355,750 | 0.87% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
NEW | 150,000 | $18,217,500 | 0.86% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 5,500,000 | $17,985,000 | 0.85% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 425,000 | $16,885,250 | 0.80% | |
| SVRA |
Savara Inc
Healthcare
|
Reduced | 4,015,000 | $14,333,550 | 0.68% | |
| BRKR |
Bruker Corp
Healthcare
|
Reduced | 440,000 | $14,295,600 | 0.68% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
NEW | 25,000 | $14,056,750 | 0.67% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 225,000 | $13,133,250 | 0.62% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 600,000 | $11,922,000 | 0.57% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
NEW | 701,700 | $10,532,517 | 0.50% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
NEW | 135,000 | $10,017,000 | 0.47% |